Overview
Quantum-Si offers benchtop proteomics platforms for single-molecule protein sequencing, enabling real-time analysis in research labs. Their Platinum and upcoming Proteus systems provide next-generation performance for biomarker discovery and therapeutic development. Key advancements include detection of up to 20 amino acids and controlled cleavage chemistry for billions of sequencing reads.
Frequently asked questions
- What protein sequencing platforms does Quantum-Si offer?
- Quantum-Si provides the Platinum Pro benchtop platform for single-molecule protein sequencing, with the Proteus platform on track for launch by end of 2026, offering improved amino acid coverage and sequencing performance.
- What are the key capabilities of Quantum-Si's technology?
- The platforms enable real-time, single-molecule detection of amino acids including glycine, methionine, and sequencing through proline-rich regions, with Proteus expected to cover 18 amino acids at launch and all 20 by 2027, plus PTM analysis.
- What is the timeline for Quantum-Si's Proteus platform?
- Proteus early access starts summer 2026, with full launch by end of 2026; pricing announced Q2 2026, launch capabilities Q3 2026, and Platinum Pro upgrade program Q3 2026.